InflaRx
0 followers
‌
InflaRx (Nasdaq: IFRX) is a clinical-stage biopharmaceutical company focused on applying its proprietary anti-C5a technology to discover and develop first-in-class, potent and specific inhibitors of C5a.
Industries
Headquarters
Employees
Links
Org chart
Niels C. Riedemann
CEO & Founder
Niels C. Riedemann
Collapse
Renfeng Guo
Chief Scientific Officer & Founder
Thomas Taapken
Chief Financial Officer
Camilla Chong
Chief Medical Officer
Nicole Bertsch
Senior Director, Head of Human Resources
Jacky Schmitt
Senior Director Manufacturing, ext.
Daniel Vetter
Senior Director, Head of IT
Wantanee Phuapradi
Senior Director, Small Molecule Drug Product Development & CMC
Timothy E. Hermes
VP, Commercial
Michelle Medovich
Head Of Marketing
